D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Sana Biotechnology
SANA
$739M
| $197K | ﹤0.01% |
+47,347
| New | +$197K |
|
2677
Annovis Bio
ANVS
$45M
| $197K | ﹤0.01% |
+24,410
| New | +$197K |
|
|
VRN
2678
DELISTED
Veren
VRN
| $196K | ﹤0.01% |
31,844
-272,647
| -90% | -$1.68M |
|
|
NAGE
2679
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $196K | ﹤0.01% |
+53,625
| New | +$196K |
|
2680
Heritage Commerce
HTBK
$630M
| $194K | ﹤0.01% |
19,642
-135,907
| -87% | -$1.34M |
|
|
RPT
2681
Rithm Property Trust Inc.
RPT
$123M
| $192K | ﹤0.01% |
57,632
-9,842
| -15% | -$32.8K |
|
2682
Target Hospitality
TH
$876M
| $192K | ﹤0.01% |
24,630
+13,291
| +117% | +$103K |
|
2683
BRC Inc
BRCC
$174M
| $191K | ﹤0.01% |
55,931
-243,564
| -81% | -$833K |
|
|
THRD
2684
DELISTED
Third Harmonic Bio
THRD
| $189K | ﹤0.01% |
+13,967
| New | +$189K |
|
2685
Revolution Medicines, Inc. Warrant
RVMDW
$2.31M
| $189K | ﹤0.01% |
1,347,439
| – | – |
|
2686
Funko
FNKO
$184M
| $188K | ﹤0.01% |
+15,383
| New | +$188K |
|
|
PAL
2687
Proficient Auto Logistics
PAL
$207M
| $188K | ﹤0.01% |
+13,248
| New | +$188K |
|
2688
Civista Bancshares
CIVB
$407M
| $186K | ﹤0.01% |
10,436
-4,826
| -32% | -$86K |
|
2689
Backblaze
BLZE
$554M
| $184K | ﹤0.01% |
28,800
-102,730
| -78% | -$656K |
|
|
BZAIW
2690
Blaize Holdings, Inc. Warrants
BZAIW
$16M
| $182K | ﹤0.01% |
900,000
| – | – |
|
2691
Inspired Entertainment
INSE
$250M
| $177K | ﹤0.01% |
19,092
-19,510
| -51% | -$181K |
|
2692
Hallador Energy
HNRG
$763M
| $175K | ﹤0.01% |
+18,581
| New | +$175K |
|
2693
Invesco KBW High Dividend Yield Financial ETF
KBWD
$428M
| $174K | ﹤0.01% |
11,376
-2,209
| -16% | -$33.8K |
|
2694
Northwest Bancshares
NWBI
$1.83B
| $165K | ﹤0.01% |
12,330
-65,217
| -84% | -$873K |
|
2695
Esperion Therapeutics
ESPR
$524M
| $164K | ﹤0.01% |
99,573
-282,915
| -74% | -$467K |
|
2696
CoreCard
CCRD
$208M
| $164K | ﹤0.01% |
+11,282
| New | +$164K |
|
2697
loanDepot
LDI
$735M
| $164K | ﹤0.01% |
+59,993
| New | +$164K |
|
2698
VanEck Mortgage REIT Income ETF
MORT
$335M
| $160K | ﹤0.01% |
13,285
-22,100
| -62% | -$267K |
|
2699
Skillz
SKLZ
$110M
| $160K | ﹤0.01% |
28,527
-2,462
| -8% | -$13.8K |
|
2700
Cabaletta Bio
CABA
$159M
| $160K | ﹤0.01% |
+33,963
| New | +$160K |
|